UNSPSC 51381701: Acetaminophen or paracetamol

This classification denotes an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but generally known as acetaminophen, which bears US NIH Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51381701 Acetaminophen or paracetamol is a Commodity code that in practice spans a much broader range of pharmaceutical and over-the-counter products than its title suggests. State and local governments soliciting under this code are purchasing generic pharmaceuticals, naloxone, OTC medications, and related health products through competitive bidding and cooperative purchasing vehicles. Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). The work involves manufacturing and wholesale distribution of pharmaceutical products meeting FDA requirements, current Good Manufacturing Practices (cGMP), and Drug Supply Chain Security Act (DSCSA) compliance, with vendors typically required to maintain authorized distributor relationships and provide detailed product coding (NDC, SKU, UPC) and pricing flexibility across multiple formats.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County posted an IFB (IFB60459723LAS) in June 2026 with a July 26, 2023 due date for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the county community health building, with a two-year term and one-year renewal option. The Texas HHS Commission issued an RFI (HHS0017013) in April 2026 to gather market intelligence on direct-to-manufacturer prescription fulfillment models outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Department of Administration's MMCAP cooperative issued an RFP (S1070000015802) in January 2026 with a March 26, 2026 response deadline for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, Morris & Dickson Co.), requiring vendors to meet cGMP and DSCSA standards, maintain $5 million commercial general liability insurance, and pay a 3 percent administrative fee on all contract purchases, with contract terms of two years for new vendors and optional extensions.